Targeted immunotherapies overtaking emerging oncology market value based growth
(2015) In Journal of B.U.ON. 20(1). p.350-351
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/b8955e2f-e0a7-4cbb-84b1-761c4c6baf13
- author
- Jakovljevic, Mihajlo B LU
- publishing date
- 2015-03-18
- type
- Contribution to journal
- publication status
- published
- keywords
- Antineoplastic Agents/economics, Budgets, Commerce, Cost Control, Cost-Benefit Analysis, Drug Costs/trends, Drug Industry/economics, Health Expenditures/trends, Health Services Accessibility/economics, Humans, Immunotherapy/economics, Medical Oncology/economics, Molecular Targeted Therapy/economics, Neoplasms/drug therapy, Serbia, Time Factors
- in
- Journal of B.U.ON.
- volume
- 20
- issue
- 1
- pages
- 350 - 351
- publisher
- Zerbinis Medical Publ.
- external identifiers
-
- scopus:84928701501
- pmid:25778340
- ISSN
- 1107-0625
- language
- English
- LU publication?
- no
- id
- b8955e2f-e0a7-4cbb-84b1-761c4c6baf13
- date added to LUP
- 2018-09-01 22:57:33
- date last changed
- 2024-05-13 14:00:43
@article{b8955e2f-e0a7-4cbb-84b1-761c4c6baf13, author = {{Jakovljevic, Mihajlo B}}, issn = {{1107-0625}}, keywords = {{Antineoplastic Agents/economics; Budgets; Commerce; Cost Control; Cost-Benefit Analysis; Drug Costs/trends; Drug Industry/economics; Health Expenditures/trends; Health Services Accessibility/economics; Humans; Immunotherapy/economics; Medical Oncology/economics; Molecular Targeted Therapy/economics; Neoplasms/drug therapy; Serbia; Time Factors}}, language = {{eng}}, month = {{03}}, number = {{1}}, pages = {{350--351}}, publisher = {{Zerbinis Medical Publ.}}, series = {{Journal of B.U.ON.}}, title = {{Targeted immunotherapies overtaking emerging oncology market value based growth}}, volume = {{20}}, year = {{2015}}, }